AnaptysBio
ANAB
#5496
Rank
C$1.98 B
Marketcap
C$66.88
Share price
-1.62%
Change (1 day)
28.25%
Change (1 year)

Earnings for AnaptysBio (ANAB)

Earnings in 2026 (TTM): C$77.14 Million

According to AnaptysBio's latest financial reports the company's current earnings are C$0.23 Billion. In 2025 the company made an earning of C$95.85 Million, an increase over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AnaptysBio from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$77.14 M-19.52%
2025 C$95.85 M-170.24%
2024 -C$0.14 Billion-34.63%
2023 -C$0.21 Billion35.27%
2022 -C$0.16 Billion92.31%
2021 -C$80.25 Million137.28%
2020 -C$33.82 Million-75.55%
2019 -C$0.14 Billion60.22%
2018 -C$86.35 Million112.74%
2017 -C$40.59 Million644.41%
2016 -C$5.46 Million-20.91%
2015 -C$6.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-378.50%๐Ÿ‡บ๐Ÿ‡ธ USA